Your browser doesn't support javascript.
loading
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.
Fu, Xiaoyong; Jeselsohn, Rinath; Pereira, Resel; Hollingsworth, Emporia F; Creighton, Chad J; Li, Fugen; Shea, Martin; Nardone, Agostina; De Angelis, Carmine; Heiser, Laura M; Anur, Pavana; Wang, Nicholas; Grasso, Catherine S; Spellman, Paul T; Griffith, Obi L; Tsimelzon, Anna; Gutierrez, Carolina; Huang, Shixia; Edwards, Dean P; Trivedi, Meghana V; Rimawi, Mothaffar F; Lopez-Terrada, Dolores; Hilsenbeck, Susan G; Gray, Joe W; Brown, Myles; Osborne, C Kent; Schiff, Rachel.
Afiliação
  • Fu X; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
  • Jeselsohn R; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
  • Pereira R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
  • Hollingsworth EF; Department of Pathology, Baylor College of Medicine, Houston, TX 77030.
  • Creighton CJ; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Li F; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
  • Shea M; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Nardone A; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Heiser LM; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239.
  • Anur P; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR 97239.
  • Wang N; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239.
  • Grasso CS; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239.
  • Spellman PT; Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR 97239.
  • Griffith OL; McDonnell Genome Institute, Washington University, St. Louis, MO 63108.
  • Tsimelzon A; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Gutierrez C; Department of Pathology, Baylor College of Medicine, Houston, TX 77030.
  • Huang S; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
  • Edwards DP; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Department of Pathology, Baylor College of Medicine, Houston, TX 77030.
  • Trivedi MV; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Pharmacy Practice and Translational Research, University of Houston, Houston, TX 77204; Department of Pharmacological and Pharm
  • Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Lopez-Terrada D; Department of Pathology, Baylor College of Medicine, Houston, TX 77030.
  • Hilsenbeck SG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medicine, Houston, TX 77030.
  • Gray JW; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239.
  • Brown M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.
  • Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medici
  • Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX 77030; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030; Department of Medicine, Baylor College of Medici
Proc Natl Acad Sci U S A ; 113(43): E6600-E6609, 2016 10 25.
Article em En | MEDLINE | ID: mdl-27791031
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / Interleucina-8 / Receptor alfa de Estrogênio / Fator 3-alfa Nuclear de Hepatócito / Transcriptoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / Interleucina-8 / Receptor alfa de Estrogênio / Fator 3-alfa Nuclear de Hepatócito / Transcriptoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2016 Tipo de documento: Article